Eric Lefofsky is a highly successful American entrepreneur who co-founded an organization known as Tempus, an initiative to help cure cancer. Tempus’s mission is to improve the overall success rate of patient outcomes. In order for this outcome to come into existence, Tempus operates by providing genomic data used within hospital settings. Through the collection of this data, Tempus analyzes this information in order to provide patients with specialized, more accurate care and medicine. This data is given to doctors that will develop better treatment options, in order to precisely treat patients. Tempus is a state-of-the-art company, utilizing technological advances including robotics to provide services for a high rate of patients, continuously.
Follow him at his facebook.com page.
Also serving as the CEO of Tempus, Eric Lefofsky has a history of being involved with technological organizations, being the co-founder of Lightbank and Groupc. With only 29 employees according to LinkedIn and managed by Lefosfsky, Tempus is forming this initiative to eventually better humanity. With a plethora of data analyzed from millions of patients, more accurate treatment will be able to be developed. More data means that doctors have access to patient’s medical history, so that they are not mistreating those that may need eager care. See forbes.com.
This initiative is only made possible by the contributions of Eric Lefofsky. He has donated millions of dollars to health initiatives, with the eventual goal of achieving accessible and affordable healthcare options. With a net worth of approximately 1.88 billion USD, Lefofsky is in the position to make a difference, and he is doing just that with Tempus. Ultimately, Tempus’s mission is to prevent mistreatment and provide accurate health care options to patients. Cancer is one of the most horrendous difficulties someone can face in their lives; it is imperative that those in positions of power and wealth, like Eric Lefofsky, have noble ambitions and band together to put and end to deadly diseases and cancers.